http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101271223-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate | 2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101271223-B1 |
| titleOfInvention | Aminopyrimidine Derivatives and Inhibitors of Extracellular Signal-regulated Kinases Comprising the Same |
| abstract | The present invention relates to a novel aminopyridine derivative having inhibitory activity against extracellular signal-regulated kinase, wherein the cell contains the novel aminopyridine derivative, the aminopyridine derivative and / or a pharmaceutically acceptable salt thereof as an active ingredient. In addition, the present invention relates to a composition for preventing and / or treating cancer, which contains an external signal-regulating kinase inhibitor and the aminopyridine derivative and / or a pharmaceutically acceptable salt thereof as an active ingredient. |
| priorityDate | 2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 472.